Joint FEAM/Wellcome Trust briefing on data protection and proposed amendments

25 / 02 / 2013

Direct‐to‐Consumer Genetic Testing for Health‐Related Purposes in the European Union

Summary report from a meeting organised by EASAC, FEAM and STOA in the European Parliament on 3 December 2012

30 / 01 / 2013

Joint statement of the Healthcare Coalition on Data Protection

And press releasePress release

29 / 01 / 2013

Summary of the FEAM statement on the Data Protection Regulation and proposed amendments to the EC proposed Regulation

25 / 11 / 2012

The perspective of EASAC and FEAM on direct-to-consumer genetic testing for health-related purposes

European Journal of Human Genetics,

21 / 11 / 2012

Summary of the report on Direct-to-consumer genetic testing for health-related purposes in the European Union: the view from EASAC and FEAM

25 / 08 / 2012

Direct-to-consumer genetic testing

The Lancet, Volume 380, Issue 9837, Page 76, 14 July 2012.

25 / 07 / 2012

Summary of FEAM Madrid conference on Ageing

4 May 2012, Spanish Royal National Academy of Medicine

30 / 06 / 2012

Direct-to-consumer genetic testing for health-related purposes in the European Union: the view from EASAC and FEAM

Report

30 / 06 / 2012

FEAM’s contribution to a special edition on One Health

Italian Journal of Public Health, Issue: 2012, Vol.9, Nr.2

25 / 06 / 2012

Summary of session on ageing

(FEAM Madrid Spring Conference 4-5 May 2012)

25 / 06 / 2012

FEAM statement on data protection regulation

summary and proposed amendments

25 / 06 / 2012

Workshop on the Benefits of a Simplified and Coherent Clinical – Trials Framework in Europe

01 / 12 / 2011

FEAM statement on the EU Physical Agents Directive (2004/40/EC)

07 / 11 / 2011

Objectives and Opportunities for EU mental health policy

Account of the launch event of the FEAM statement on Mental Health Policy Issues (22 March 2011, European Parliament)

25 / 08 / 2011

Taking forward reform of the EU Clinical Trials Directive

Account of the launch event of the FEAM statement Opportunities and Challenges for Reforming the EU Clinical Trials Directive: an Academic Perspective (25 January 2011, European Parliament)

25 / 07 / 2011

European mental health policy: opportunities for science and innovation, challenges for implementation

(Robin Fears; Cyril Hoschl; The European Journal of Public Health 2011; doi: 10.1093/eurpub/ckr075). Free-access links to EJPH advance access page (October 2011 edition): Full Text: http://eurpub.oxfordjournals.org/cgi/content/full/ckr075? ijkey=Qt7fUZDrzfJIzbm&keytype=ref

25 / 07 / 2011

A response from FEAM to the European Commission consultation on the Green Paper ‘From Challenges to Opportunities

Towards a Common Strategic Framework for EU Research and Innovation funding'

25 / 05 / 2011

FEAM submission to the 2011 European Commission concept paper: revision of the ‘Clinical Trials Directive’ 2001/20/EC

25 / 05 / 2011

Mental health policy issues

the view from FEAM', an article by Robin Fears and Cyril Höschl on behalf of the FEAM Working Group, published in the January edition of EPA Journal (Eur Psychiatry 2011, vol 26, issue 1, pp. III-VI)

25 / 01 / 2011

FEAM Statement on Mental Health Policy Issues

25 / 11 / 2010

FEAM Statement ‘Opportunities and Challenges for Reforming the EU Clinical Trials Directive: an Academic Perspective’

25 / 09 / 2010

Consultation on Functioning of the Clinical Trials Directive

FEAM response

25 / 02 / 2010

Summary of the session on personalised medicine

Paris conference

31 / 10 / 2008

Report on Regenerative Medicine: basic and clinical research

Rome conference

25 / 12 / 2007